Ad
SKYE Quote Trading Chart Skye Bioscience Inc Com
home / stock / skye / skye quote
Quote | Skye Bioscience Inc Com (NASDAQ:SKYE)
| Last: | $1.82 |
|---|---|
| Change Percent: | -1.68% |
| Open: | $1.82 |
| Close: | $1.82 |
| High: | $1.92 |
| Low: | $1.75 |
| Volume: | 415,401 |
| Last Trade Date Time: | 04/25/2025 03:40:20 pm |
Quotes are delayed by 15 to 20 minutes.
SKYE Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $1.82 | $1.82 | $1.82 | $1.92 | $1.75 | 415,401 | 04-25-2025 |
| $1.79 | $1.71 | $1.79 | $1.81 | $1.63 | 331,211 | 04-24-2025 |
| $1.73 | $1.55 | $1.73 | $1.73 | $1.48 | 453,083 | 04-23-2025 |
| $1.51 | $1.55 | $1.51 | $1.63 | $1.45 | 466,712 | 04-22-2025 |
| $1.57 | $1.4 | $1.57 | $1.58 | $1.36 | 568,349 | 04-21-2025 |
| $1.435 | $1.58 | $1.435 | $1.65 | $1.41 | 587,704 | 04-18-2025 |
| $1.435 | $1.58 | $1.435 | $1.65 | $1.41 | 587,704 | 04-17-2025 |
| $1.58 | $1.63 | $1.58 | $1.75 | $1.52 | 1,166,500 | 04-16-2025 |
| $1.71 | $1.48 | $1.71 | $3.727 | $1.48 | 27,436,526 | 04-15-2025 |
| $1.31 | $1.43 | $1.31 | $1.45 | $1.26 | 173,868 | 04-14-2025 |
| $1.41 | $1.33 | $1.41 | $1.41 | $1.3 | 140,480 | 04-11-2025 |
| $1.34 | $1.34 | $1.34 | $1.4 | $1.24 | 123,199 | 04-10-2025 |
| $1.35 | $1.15 | $1.35 | $1.37 | $1.15 | 191,445 | 04-09-2025 |
| $1.2 | $1.43 | $1.2 | $1.445 | $1.14 | 274,133 | 04-08-2025 |
| $1.39 | $1.22 | $1.39 | $1.42 | $1.22 | 153,069 | 04-07-2025 |
| $1.3 | $1.28 | $1.3 | $1.34 | $1.2201 | 198,659 | 04-04-2025 |
| $1.4 | $1.38 | $1.4 | $1.43 | $1.26 | 282,791 | 04-03-2025 |
| $1.43 | $1.41 | $1.43 | $1.44 | $1.41 | 103,318 | 04-02-2025 |
| $1.4 | $1.57 | $1.4 | $1.615 | $1.37 | 349,263 | 04-01-2025 |
| $1.59 | $1.81 | $1.59 | $1.85 | $1.56 | 455,107 | 03-31-2025 |
News, Short Squeeze, Breakout and More Instantly...
Skye Bioscience Inc Com Company Name:
SKYE Stock Symbol:
NASDAQ Market:
-1.68% G/L:
$1.82 Last:
415,401 Volume:
$1.82 Open:
$1.82 Close:
Skye Bioscience Inc Com Website:
Ad
-
2025-04-15 10:34:57 ET DENVER, Colo., Apr 15, 2025 ( 247marketnews.com ) -Today’s top news and trades include weight loss and super fibers. MetaVia (NASDAQ:MTVA) unveiled Phase 1 MAD trial results for DA-1726, its novel 3:1 ratio GLP-1/glucagon dual receptor agonist aimed at ...
-
Papaya Growth Opportunity Corp. I (PPYA) is expected to report for quarter end 2024-12-31 KinderCare Learning Companies Inc. (KLC) is expected to report $0.04 for Q4 2024 Recordati SpA (RCDTF) is expected to report for quarter end 2024-12-31 InflaRx N.V. (IFRX) is expected to report $...
-
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, is pleased to announce the participation of Punit Dh...